I realize the actual charges are for different things, but I find myself comparing Shkreli's actions of hiking up daraprim prices to John Kapoor's fraud charges

I realize the actual charges are for different things, but I find myself comparing Shkreli's actions of hiking up daraprim prices to John Kapoor's fraud charges to sell opioids ( https://arstechnica.com/tech-policy/2017/10/doj-billionaire-pharma-owner-fueled-the-opioid-epidemic-with-bribery-scheme/ https://arstechnica.com/tech-policy/2017/10/doj-billionaire-... ). So far one of the doctors involved in the latter case got four years ( https://www.bloomberg.com/news/articles/2018-03-09/ivy-league-doctor-gets-4-years-prison-for-insys-opioid-kickbacks https://www.bloomberg.com/news/articles/2018-03-09/ivy-leagu... ). More light needs to be shined on Kapoor's case (and the practices in Big Pharma in general) if it's impacting more lives. I don't like Shkreli's obnoxiousness, yet tried listening to his reasoning in why he raised the daraprim price versus other drugs. His talk last year at Harvard ( https://www.youtube.com/watch?v=n3bpXHMP4ww https://www.youtube.com/watch?v=n3bpXHMP4ww ) dives a bit into the thought process.